Ticker Symbol: VSTM
Verastem Inc
$3.20 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001526119
Company Profile
Verastem Oncology is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. The company's pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 117 Kendrick St Ste 500
Website: www.verastem.com
CEO: Brian Stuglik
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $7.90
Change:
$0.06
(
0.77%)
Days Range: $7.56 - $7.95
Beta: -
52wk. High: $15.18
52wk. Low: $3.60
Ytd. Change 63.08%
50 Day Moving Average: $8.69
200 Day Moving Average: $8.25
Shares Outstanding: 25250711
Valuation
Market Cap: 19.9B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A